Synthesis and Biological Evaluation of Pyrazolo[3,4-b]pyridin-4-ones as a New Class of Topoisomerase II Inhibitors

Author(s): Mojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Stefania Baraldi, Filippo Prencipe, Delia Preti, Giulia Saponaro, Romeo Romagnoli, Stefania Gessi, Stefania Merighi, Angela Stefanelli, Debora Fazzi, Pier Andrea Borea, Rodolfo Couto Maia, Nelilma C. Romeiro, Carlos A. M. Fraga, Eliezer J. Barreiro.

Journal Name: Medicinal Chemistry

Volume 11 , Issue 4 , 2015

Submit Manuscript
Submit Proposal

Graphical Abstract:


A series of 1,3,6-triphenylpyrazolo[3,4-b]pyridin-4-one derivatives was designed, synthesized and evaluated for cytotoxic activity in A375 human melanoma and human erythroleukemia (HEL) cells. The new pyrazolopyridones displayed comparable activities to the antitumor compound etoposide. The inhibitory effect of compounds 17, 18, 27 and 32 against topoisomerase II-mediated cleavage activities was measured finding good correlation with the results obtained from MTS assay. Docking studies into bacterial topoisomerase II (DNA Gyrase), topoisomerase IIα and topoisomerase IIβ binding sites in the DNA binding interface were performed.

Keywords: Pyrazolo[3, 4-b]pyridine, etoposide, topoisomerase, docking studies.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [342 - 353]
Pages: 12
DOI: 10.2174/1573406411666141210141317
Price: $58

Article Metrics

PDF: 36